Financial Partners Capital Management’s Cognition Therapeutics CGTX Stock Holding History

Financial Partners Capital Management’s Portfolio CGTX Stock Details CGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$29.9K	Buy	+14,228	New	+$28.7K	0.01%	115

Other funds holding CGTX

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

PWM

Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Financial Partners Capital Management's CGTX Position: Q4 2022 in Review

Financial Partners Capital Management opened a new position in Cognition Therapeutics (CGTX) in Q4 2022: 14,228 shares worth $29.9K. The stake represents 0.01% of the portfolio and ranks #115 among its holdings.

34 funds tracked by Wall St. Rank hold CGTX as of Q4 2022.

Financial Partners Capital Management held 14,228 shares of Cognition Therapeutics worth $29.9K as of Q4 2022.
Cognition Therapeutics was a new Financial Partners Capital Management position in Q4 2022.
Cognition Therapeutics made up 0.01% of Financial Partners Capital Management's portfolio in Q4 2022, its #115 holding.
34 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q4 2022.

Based on Financial Partners Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.